RecruitingPhase 4NCT07434635
APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
Sponsor
University of California, San Francisco
Enrollment
62 participants
Start Date
Feb 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- patient undergoing vitrectomy surgery
- able to give informed consent
Exclusion Criteria3
- post-operative eyedrop regimens that include topical non steroidal anti-inflammatory medications
- subjects with altered post-operative eyedrop schedule for enhanced inflammation control
- documented allergy to atropine
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAtropine 1%
Subtraction of atropine eyedrops from post-operative treatment regimen
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07434635